Stock RSPI RESPIRERX PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications RespireRx Pharmaceuticals Inc.

Equities

RSPI

US7612273059

Delayed OTC Markets
Other stock markets
 01:32:54 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.00087 USD +2.35% Intraday chart for RespireRx Pharmaceuticals Inc. +12.50% 0.00%
Apr. 10 RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding CI
Mar. 20 RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. RSPI Stock
  4. News RespireRx Pharmaceuticals Inc.
  5. Official Publications